studi
role
precursor
membran
protein
prm
flaviviru
matur
inhibit
proteolyt
process
murray
valley
enceph
mve
viru
prm
membran
protein
infect
cell
ad
acidotrop
agent
ammonium
chlorid
late
viru
replic
cycl
virus
purifi
supernat
ammonium
chloridetr
cell
contain
prm
protein
unabl
fuse
mosquito
cell
without
ammonium
chlorid
remov
cell
process
prm
fusion
activ
purifi
virus
partial
restor
use
monoclon
antibodi
mab
specif
envelop
e
glycoprotein
mve
viru
found
least
three
epitop
less
access
correspond
antibodi
prmcontain
mve
viru
particl
aminotermin
sequenc
proteolyt
fragment
e
protein
reactiv
sequencespecif
peptid
antisera
mab
enabl
us
estim
site
e
protein
interact
prm
within
amino
acid
sinc
prmcontain
virus
resist
low
ph
environ
conclud
eprm
interact
might
necessari
protect
e
protein
irrevers
conform
chang
caus
matur
acid
vesicl
exocyt
pathway
envelop
virus
enter
target
cell
viruscel
membran
fusion
must
take
place
releas
nucleocapsid
cytoplasm
occur
either
directli
plasma
membran
paramyxovirus
herpesvirus
endosom
vesicl
virus
taken
receptormedi
endocytosi
togavirus
orthomyxovirus
review
see
marsh
heleniu
gener
fusionmedi
envelop
protein
activ
proteolyt
cleavag
spike
precursor
protein
host
proteas
late
viru
assembl
cleavag
activ
glycoprotein
involv
fusion
demonstr
murin
coronavirus
sturman
holm
sturman
et
al
ha
influenza
virus
wiley
skehel
retrovirus
mccune
et
al
willey
et
al
alphavirus
lobig
garoff
lobig
et
white
et
al
cleav
glycoprotein
eg
ha
undergo
irrevers
conform
chang
acid
ph
milieu
endocyt
vesicl
expos
hydrophob
fusion
site
mediat
viruscel
membran
fusion
cleavag
precursor
protein
essenti
viru
infect
particl
format
semliki
forest
viru
sfv
mutant
defect
cleavag
express
cell
reprint
request
address
surfac
function
low
phtrigger
celltocel
fusion
lobig
garoff
lobig
et
al
murray
valley
enceph
mve
viru
member
flavivirida
famili
small
positivestrand
rna
virus
matur
flavivirion
contain
three
structur
protein
capsid
c
membran
envelop
e
molecular
mass
kda
respect
e
protein
structur
protein
respons
induct
neutral
hemagglutinationinhibit
protect
antibodi
receptorbind
protein
also
involv
acidcatalyz
membran
fusion
heinz
roehrig
guirakhoo
et
al
littl
known
function
protein
protein
cleav
precursor
protein
prm
consensu
sequenc
rxrkr
shortli
viru
releas
westaway
cleavag
associ
rearrang
oligomer
structur
surfac
virion
wengler
wengler
use
monoclon
antibodi
mab
proteas
map
previous
demonstr
e
glycoprotein
tickborn
enceph
tbe
viru
undergo
irrevers
conform
chang
predominantli
epitop
domain
mildli
acid
ph
consist
purifi
tbe
viru
demonstr
fusion
without
ffwo
mosquito
cell
line
exposur
cellbound
viru
low
ph
ffwo
abolish
process
prm
interrupt
use
acidotrop
agent
ammonium
chlorid
guirakhoo
et
paper
identifi
epitop
e
protein
cover
dissoci
presenc
prm
demonstr
prmcontain
virus
resist
low
ph
local
site
e
protein
involv
eprm
interact
final
hypothes
associ
eprm
necessari
authent
express
e
protein
product
analysi
immatur
viru
particl
aed
albopictu
cell
clone
grown
microcarri
cytodex
pharmacia
fine
chemic
upsala
sweden
dulbecco
minim
essenti
medium
dmem
buffer
mni
hepe
supplement
fetal
calf
serum
fc
hyclon
laboratori
inc
logan
ut
cell
infect
mve
viru
strain
ord
river
multipl
infect
moi
dmem
fc
ammonium
chlorid
mm
ad
hr
postinfect
pi
virus
harvest
day
time
ammonium
chloridecontain
medium
replac
dmem
fc
without
ammonium
chlorid
virus
reharvest
day
pi
virus
precipit
polyethylen
glycol
fisher
scientif
fair
lawn
nj
purifi
two
cycl
glyceroltartr
gradient
obijeski
et
al
resuspend
ml
dmem
protein
concentr
determin
biorad
protein
assay
biorad
laboratori
richmond
ca
untreat
mve
virus
without
ammonium
chlorid
propag
purifi
describ
use
posit
control
experi
acid
resist
experi
see
mve
virus
also
grown
mammalian
cell
presenc
absenc
ammonium
chlorid
quantifi
amount
viral
structur
protein
propag
purifi
virus
subject
sdspage
acryamid
gel
laemmli
protein
stain
use
rapid
silver
stain
kit
icn
cleveland
oh
accord
manufactur
protocol
gel
scan
microprocessorcontrol
spectrophotomet
gilford
system
peak
correspond
viral
protein
identifi
integr
determin
area
peak
area
ratio
prm
e
calcul
purifi
virus
dilut
geometr
pgmi
dmem
contain
bsa
thirti
microlit
dilut
ad
prechil
cell
fusion
assay
perform
ph
number
nuclei
number
cell
five
microscop
field
magnif
oofold
count
fusion
index
l
number
cell
number
nuclei
calcul
captur
enzymelink
immunosorb
assay
elisa
microtit
plate
coat
overnight
dilut
rabbit
antimv
hyperimmun
serum
dilut
captur
antibodi
determin
boxtitr
mand
prmcontain
viru
seed
maxim
standard
concentr
captur
antigen
well
block
goat
serum
pb
dilut
tissu
cultur
contain
prmor
mmve
viru
ad
plate
incub
hr
ascit
variou
mab
titrat
virus
hr
start
dilut
depend
antibodi
potenc
bound
mab
detect
goat
antimous
alkalin
phosphatas
conjug
quantit
bound
conjug
determin
ad
sigma
substrat
read
absorb
nm
titertek
mc
spectrophotomet
min
specif
biolog
activ
mab
except
publish
elsewher
hawk
et
mab
prepar
japanes
enceph
viru
strain
nakayama
use
standard
hybridoma
techniqu
mab
react
member
mve
viru
serocomplex
block
mve
virusmedi
hemagglutin
neutral
mve
viru
infect
vitro
e
glycoprotein
epitop
defin
design
acid
sensit
mve
viru
epitop
determin
use
modif
standard
elisa
protocol
two
hundr
fifti
microlit
purifi
mve
viru
pg
total
protein
trishci
ph
adjust
ph
use
hci
incub
min
acidtr
viru
untreat
viru
ph
sampl
dilut
ml
carbon
buffer
ph
lmmulon
ii
microtit
plate
coat
viru
per
well
incub
overnight
plate
block
hr
bsa
pb
protein
mab
dilut
geometr
pgwell
total
protein
ad
well
hr
plate
wash
incub
dilut
goat
antimous
alkalin
phosphatas
conjug
bound
antibodi
detect
addit
sigma
substrat
absorb
measur
nm
min
although
antibodi
test
dilut
seri
result
gg
antibodi
report
analysi
mab
reactiv
reduc
nonreduc
mve
viru
page
sampl
buffer
laemmli
without
reduc
agent
ad
pg
purifi
mve
viru
sampl
boil
min
separ
sd
gel
protein
transfer
nitrocellulos
sheet
towbin
et
block
goat
serum
reactiv
mab
defin
epitop
reduc
nonreduc
form
mve
viru
e
glycoprotein
assess
use
goat
antimous
alkalin
phosphatas
conjug
jackson
lmmuno
research
west
grove
pa
proteolyt
digest
nativ
mve
viru
perform
dmem
ph
use
predetermin
concentr
either
trypsin
proteas
sigma
chemic
co
fragment
react
mab
identifi
use
goat
antimous
alkalin
phosphatas
conjug
see
proteolyt
digest
predenatur
viru
pg
purifi
mve
viru
dmem
precipit
tca
end
concentr
ice
bath
min
wash
cold
aceton
resuspend
tri
ph
contain
sd
glycerol
hr
incub
sampl
boil
min
subject
proteolyt
digest
use
either
chymotrypsin
proteas
sigma
chemic
co
protein
enzym
ratio
l
respect
min
addit
sd
final
concentr
sampl
boil
separ
sd
gel
fragment
transfer
nitrocellulos
membran
electroblot
towbin
et
al
nitrocellulos
block
goat
serum
pb
ph
hr
strip
cut
incub
either
mab
defin
epitop
mous
sera
immun
especif
synthet
peptid
follow
mve
amino
acid
mve
amino
acid
mve
amino
acid
mve
amino
acid
sequenc
characterist
antipeptid
publish
previous
roehrig
eta
hr
goat
antimous
alkalin
phosphatas
conjug
jackson
lmmuno
research
ad
immun
fragment
visual
ad
bcipnbt
substrat
kpi
inc
gaithersburg
md
aminotermin
sequenc
fragment
prepar
describ
except
electroblot
perform
polyvinyliden
difluorid
pvdf
membran
immobilonp
millipor
bedford
use
cap
transfer
buffer
mm
cap
mm
dithiothreitol
dtt
methanol
adjust
ph
nach
fragment
stain
coomassi
blue
baker
methanol
acet
acid
aminotermin
sequenc
determin
either
appli
biosystem
foster
citi
ca
porton
instrument
tarzana
ca
protein
sequenc
use
standard
edman
chemistri
plaqu
assay
prmand
mcontain
mve
virus
exposur
differ
ph
buffer
equal
amount
plaqu
form
unit
pfu
x
omi
virus
grown
cell
x
virus
grown
cell
supernat
ammonium
chloridetr
untreat
mve
virusinfect
cell
incub
differ
ph
buffer
rang
use
hepe
me
contain
dmem
minincub
room
temperatur
inoculum
exponenti
dilut
diluent
hunt
eta
examin
infect
vero
cell
use
standard
plaqu
assay
relationship
prm
process
fusion
activ
understand
role
prm
protein
viru
matur
interact
e
glycoprotein
investig
effect
ammonium
chlorid
mve
virus
grown
mosquito
cell
ammonium
chlorid
shown
accumul
postgolgi
acid
vesicl
interrupt
process
prm
protein
randolph
eta
unprocess
prm
protein
incorpor
releas
virus
grown
presenc
ammonium
chlorid
day
pi
fig
lane
ammonium
chlorid
remov
cell
partial
recov
normal
process
prm
resum
fig
la
lane
sinc
unprocess
prm
protein
also
found
mveinfect
cell
absenc
ammonium
chlorid
fig
lane
l
attempt
quantifi
amount
prm
sampl
achiev
scan
stain
viral
protein
follow
separ
sdspage
use
nonradioact
virus
alway
possibl
clearli
demonstr
presenc
small
protein
minigel
fact
ratio
viral
structur
protein
absenc
ammonium
chlorid
remain
constant
enabl
us
evalu
amount
prm
process
indirectli
calcul
ratio
structur
protein
e
c
abund
virion
ratio
area
peak
correspond
c
prm
protein
e
well
prm
c
protein
calcul
ratio
c
e
protein
remain
constant
presenc
absenc
ammonium
chlorid
data
shown
wherea
ratio
prm
e
protein
significantli
increas
presenc
ammonium
chlorid
reduc
follow
remov
ammonium
chlorid
fig
similar
result
obtain
ratio
prm
c
calcul
data
shown
data
confirm
partial
recoveri
prm
process
occur
ammonium
chlorid
remov
determin
fusion
activ
virus
obtain
supernat
virusinfect
ammonium
chloridetr
cell
ffwo
assay
perform
use
monolay
cell
describ
previous
guirakhoo
et
polykaryocyt
format
observ
pgml
purifi
viru
use
virus
harvest
presenc
ammonium
chlorid
day
pi
howev
ammonium
chlorid
remov
fusion
activ
purifi
virus
obtain
day
significantli
restor
fig
b
result
agreement
previou
find
tbe
viru
demonstr
direct
relationship
process
prm
fusion
activ
e
glycoprotein
guirakhoo
eta
manifest
phenomena
revers
epitop
analysi
eprotein
prmand
mcontain
virus
captur
elisa
perform
analyz
effect
block
prm
cleavag
express
e
glycoprotein
epitop
nativ
virion
reactiv
mab
defin
nine
distinct
epitop
mve
e
glycoprotein
compar
mand
prmcontain
virus
use
supernat
ammonium
chloridetr
untreat
virusinfect
cell
antigen
prmand
mcontain
viru
supernat
equival
endpoint
elisa
antigen
titrat
use
dilut
polyclon
rabbit
antimv
viru
captur
sera
antimv
viru
mous
hyperimmun
ascit
fluid
hiaf
detector
therefor
dilut
supernat
use
subsequ
epitop
map
mab
equival
antigen
confirm
endpoint
elisa
titrat
mve
hiaf
standard
captur
assay
fig
even
though
viru
supernat
equal
antigen
prmcontain
viru
supernat
ofold
less
infecti
mcontain
viru
supernat
x
vs
x
pfuml
reactiv
three
e
glycoprotein
epitop
significantli
reduc
prmcontain
virus
fig
two
epitop
subcomplexand
complexreact
one
groupreact
conserv
flavivirus
hawk
et
al
reactiv
mve
virusspecif
mab
ident
virus
fig
structur
properti
epitop
correspond
mab
assess
compar
reactiv
mab
incub
purifi
virus
low
ph
untreat
virus
fig
seen
antigen
reactiv
mab
hiaf
significantli
reduc
upon
low
ph
treatment
viru
mab
bind
site
e
glycoprotein
figur
demonstr
reactiv
three
mab
defin
epitop
mve
viru
e
glycoprotein
reduc
nonreduc
condit
seen
neither
mab
recogn
e
protein
duce
form
treat
wherea
mab
still
reactiv
protein
reduct
reactiv
sustain
reduct
alkyl
cystein
residu
e
glycoprotein
use
dltsd
follow
iodoacetamid
treatment
johnson
et
data
shown
sinc
reactiv
mab
reduc
prmcontain
virus
fact
could
recogn
e
protein
immunoblot
linear
conform
attempt
obtain
inform
site
involv
prme
interact
identifi
bind
site
proteolyt
digest
nativ
e
protein
trypsin
cleav
k
r
endoproteinas
cleav
e
produc
fragment
smaller
kda
reactiv
mab
fig
order
produc
smaller
fragment
reactiv
mab
mve
viru
denatur
sd
prior
proteas
digest
use
chymotrypsin
cleav
f
proteas
fragment
fr
fr
identifi
respect
two
fragment
react
mab
also
recogn
mous
antiserum
immun
synthet
peptid
mve
fig
fragment
fr
fragment
fr
produc
use
chymotrypsin
respect
recogn
mve
antibodi
mve
antibodi
mab
antisera
prepar
mve
also
recogn
fragment
kda
fr
fig
fr
sequenc
aminotermin
end
result
shown
ta
dalgarno
et
predict
one
potenti
nlink
glycosyl
site
e
protein
posit
nl
fact
site
might
contain
carbohydr
complex
type
endo
h
resist
winkler
shown
west
nile
viru
e
prm
glycoprotein
remain
heterodim
transport
matur
acid
compart
exocyt
rout
wengler
wengler
compar
infect
prmcontain
mve
viru
mcontain
mve
viru
follow
viru
exposur
acid
condit
equal
pfu
prmand
mviru
contain
supernat
cell
subject
environ
differ
ph
valu
result
infect
plaqu
assay
examin
fig
signific
differ
infect
either
viru
prepar
observ
incub
virus
ph
valu
upon
incub
ph
infect
mcontain
virus
grown
cell
drastic
abolish
howev
loss
infect
less
dramat
prmcontain
virus
mcontain
virus
loss
versu
loss
virus
grown
cell
fig
tion
fr
start
posit
predict
bind
site
amino
acid
e
glycoprotein
fig
low
ph
sensit
prmand
mcontain
mve
virus
tabl
mark
arrowhead
fragment
gener
digest
sdsdenatur
purifi
mve
viru
separ
sd
gel
transfer
pvdf
membran
western
blot
membran
stain
coomassi
blue
subject
aminotermin
sequenc
analysi
fragment
gener
describ
transfer
nitrocellulos
subject
immun
detect
use
mve
antipeptrd
antibodi
sequenc
length
see
materi
method
mab
describ
materi
method
virus
grown
cell
fig
maxim
loss
infect
achiev
upon
incub
ph
nevertheless
prmcontain
virus
still
ofold
grown
cell
grown
cell
resist
low
ph
environ
mcontain
virus
proteolyt
cleavag
prm
occur
dibas
amino
acid
motif
presum
trypsinlik
host
enzym
similar
respons
normal
process
prohormon
fischer
scheller
steiner
al
recent
enzym
design
pair
basic
amino
acid
cleav
enzym
pace
clone
purifi
human
liver
cell
line
wise
et
al
similar
endoproteas
also
isol
transgolgi
membran
rat
liver
cell
shown
cleav
vitro
f
protein
new
castl
diseas
viru
dibas
residu
motif
sakaguchi
et
al
believ
late
matur
process
prm
rxrkr
cleavag
motif
mechan
use
activ
flaviviru
fusion
protein
e
glycoprotein
infect
prmcontain
virus
grown
cell
mammalian
cell
lofold
lower
matur
mve
mcontain
virus
although
amount
antigen
detect
polyclon
antibodi
similar
virus
result
indic
prm
process
requir
full
viru
infect
similar
observ
made
west
nile
wn
viru
ratio
physic
particl
pfu
fulli
infecti
extracellular
mcontain
virus
higher
cellassoci
prmcontain
virus
wengler
wengler
upon
subsequ
infect
endocytosi
e
glycoprotein
probabl
undergo
conform
chang
acid
environ
endocyt
vesicl
result
membran
fusion
releas
nucleocapsid
cytoplasm
consist
hypothesi
previou
find
e
glycoprotein
tbe
viru
undergo
irrevers
conform
chang
ph
less
chang
predominantli
occur
adomain
epitop
site
mandl
et
al
probabl
necessari
trigger
fusion
activ
e
glycoprotein
shown
fusion
activ
tbe
viru
block
effect
three
mab
two
specif
epitop
adomain
one
recogn
epitop
guirakhoo
et
al
adomain
contain
amino
acid
sequenc
g
l
f
g
conserv
fusion
sequenc
envelop
virus
also
observ
dengu
viru
region
contain
conserv
fusion
sequenc
access
antipeptid
antibodi
follow
low
ph
treatment
use
mab
specif
mve
viru
e
glycoprotein
captur
elisa
demonstr
process
prm
interrupt
least
three
epitop
e
glycoprotein
less
access
viru
particl
observ
epitop
acid
sensit
indic
probabl
locat
adomain
sensit
hiaf
low
ph
also
suggest
epitop
predomin
epitop
recogn
follow
immun
intact
viru
may
signific
three
epitop
associ
hemagglutin
red
blood
cell
least
one
epitop
also
elicit
virusneutr
antibodi
sinc
function
import
epitop
induc
neutral
hemagglutinationinhibit
protect
antibodi
hawk
et
still
present
prmcontain
virus
fig
fact
virus
still
capabl
bind
infect
host
cell
expect
fusion
peptid
receptorbind
site
would
directli
involv
prme
interact
confirm
immunereact
fragment
gener
proteas
sequenc
shown
predominantli
three
site
e
glycoprotein
expos
proteolyt
attack
enzym
cleavag
occur
posit
gener
four
fragment
reactiv
sequencespecif
antipeptid
antibodi
mab
similar
segment
e
protein
wn
viru
locat
also
shown
expos
proteolyt
attack
wengler
er
combin
result
reactiv
pattern
antipeptid
antibodi
proteolyt
fragment
also
inform
obtain
ntermin
sequenc
analysi
immun
fragment
abl
map
bind
site
mab
cover
dissoci
presenc
prm
site
resid
amino
acid
e
protein
includ
domain
propos
wn
nowak
wengier
mve
roehrig
et
virus
actual
biolog
function
domain
previous
identifi
noteworthi
synthet
peptid
mve
consist
amino
acid
within
domain
crossreact
member
flavivirus
roehrig
et
al
indic
biolog
import
region
sever
studi
indic
influenza
viru
semliki
forest
viru
incub
low
ph
becam
irrevers
inactiv
dom
et
kielian
heleniu
stegman
eta
white
et
probabl
due
exposur
selfaggreg
hydrophob
fusion
peptid
therefor
longer
interact
target
membran
nir
et
al
flaviviru
e
glycoprotein
protect
transport
cell
surfac
acid
milieu
postgolgi
vesicl
could
inactiv
shown
wn
viru
e
prm
protein
remain
heterodim
exocytosi
wengler
wengler
reason
function
prm
prevent
conform
chang
e
glycoprotein
low
ph
thu
assur
safe
transport
protein
postgolgi
acid
vesicl
matur
virion
releas
similar
role
also
propos
alphavirus
form
stabl
dimer
el
protein
critic
infect
fusion
acid
compart
exocyt
rout
lobig
garoff
presley
et
wahlberg
et
al
differ
approach
might
util
virus
secur
authent
express
envelop
protein
infect
cell
shown
protein
influenza
viru
rais
ph
postgolgi
vesicl
unit
thu
prevent
express
low
ph
conform
ha
molecul
plasma
membran
infect
cell
ciampor
et
high
resist
prmcontain
virus
low
ph
might
indic
prm
could
shield
segment
e
protein
otherwis
proton
low
ph
environ
lead
exposur
fusion
peptid
consequ
loss
infect
concomit
low
ph
sensit
mcontain
virus
loss
epitop
reactiv
elisa
follow
incub
ph
prmcontain
virus
still
infecti
appar
prm
protein
cleav
viru
undergon
endocytosi
use
chymotrypsin
trypsin
thermolysin
demonstr
prm
protein
wn
viru
highli
sensit
proteas
laboratori
also
observ
use
low
concentr
trypsin
prm
protein
mve
viru
cleav
prior
e
protein
data
shown
result
predict
express
authent
e
glycoprotein
requir
coexpress
prm
would
explain
flaviviru
vaccin
candid
produc
express
e
glycoprotein
partial
protect
homotyp
challeng
wherea
prepar
express
prm
e
glycoprotein
gave
signific
level
protect
bray
lai
similar
result
observ
japanes
enceph
viru
high
neutral
hemagglutinationinhibit
antibodi
correl
high
level
protect
found
mice
inocul
recombin
vaccin
virus
express
prm
e
e
protein
alon
konishi
et
al
yasuda
et
current
perform
experi
defin
role
prm
viru
infect
event
occur
prmcontain
virus
enter
target
cell
also
attempt
determin
similar
area
e
protein
flavivirus
involv
prm
interact
